Skip to content

CTMX - CytomX Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

CytomX Therapeutics Inc

CTMX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

CTMXCytomX Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $8.21
52-wk low: $1.90
Prev close: $5.13
Mkt cap: $738.7M
Fwd P/E: 14.2x
Beta: 2.14

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$356.9M

P7
Point72
Steven Cohen · Q2 2026 13F
$29.3M
position
TS
Two Sigma
Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 18.2% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 14.20
Market cap: $739M

Valuation

P/S40.36
P/B2.48

Quality

Operating margin-1677.0%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: CTMX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $738.68M
Beta: 2.14

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

40.4x

P/B

2.5x

Profit margin

+0.0%

Op margin

-1677.0%

ROE

-37.8%

$15.5M

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$11.7M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for CTMX

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.09+18.2%

-$0.11 expected

Next report

What the street expects next

ROE

-37.8%

ROA-19.6%

Growth

Beta2.14